Preclinical Activities Sample Clauses

Preclinical Activities. For each R&D Project, preclinical activities-related costs shall be borne as follows: 4.4.1.1. All internal costs incurred by a Party in the performance of R&D Project preclinical activities shall be exclusively borne by such Party; 4.4.1.2. All external costs incurred by the Parties in the performance of R&D Project preclinical activities (including but not limited to those related to in vivo preclinical test subcontractors) shall be exclusively borne by GenSight; 4.4.1.3. All internal and external costs incurred by Genethon to manufacture research quality grade batches of Product shall be exclusively borne by Genethon; 4.4.1.4. Genethon shall assume the costs (internal and external) incurred to manufacture all batches, whether GMP or not, of Product to be used for regulatory preclinical toxicology studies, and if applicable, one GMP batch for the initial phase I clinical studies, which may or may not be the same batch as a batch that was used for preclinical toxicology.